ALHC icon

Alignment Healthcare

18.08 USD
-0.54
2.90%
At close Apr 1, 3:59 PM EDT
After hours
18.02
-0.06
0.33%
1 day
-2.90%
5 days
3.02%
1 month
16.49%
3 months
56.40%
6 months
80.80%
Year to date
56.40%
1 year
266.73%
5 years
4.45%
10 years
4.45%
 

About: Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.

Employees: 1,679

0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 7 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

585% more call options, than puts

Call options by funds: $21.2M | Put options by funds: $3.09M

336% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 11

86% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 36

50% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 3 (+1) [Q4]

26% more funds holding

Funds holding: 136 [Q3] → 171 (+35) [Q4]

4.87% more ownership

Funds ownership: 87.09% [Q3] → 91.95% (+4.87%) [Q4]

1% more capital invested

Capital invested by funds: $1.97B [Q3] → $1.98B (+$15.6M) [Q4]

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$9
50%
downside
Avg. target
$16.79
7%
downside
High target
$21
16%
upside

7 analyst ratings

positive
71%
neutral
14%
negative
14%
JP Morgan
Lisa Gill
74% 1-year accuracy
17 / 23 met price target
6%downside
$17
Neutral
Maintained
6 Mar 2025
Piper Sandler
Jessica Tassan
38% 1-year accuracy
9 / 24 met price target
16%upside
$21
Overweight
Maintained
4 Mar 2025
B of A Securities
Adam Ron
75% 1-year accuracy
3 / 4 met price target
2%upside
$18.50
Buy
Maintained
4 Mar 2025
Stifel
Craig Jones
56% 1-year accuracy
5 / 9 met price target
0%downside
$18
Buy
Maintained
28 Feb 2025
Barclays
Andrew Mok
41% 1-year accuracy
24 / 58 met price target
50%downside
$9
Underweight
Maintained
28 Feb 2025

Financial journalist opinion

Neutral
Zacks Investment Research
3 weeks ago
Is Alignment Healthcare (ALHC) Stock Outpacing Its Medical Peers This Year?
Here is how Alignment Healthcare (ALHC) and Fresenius (FMS) have performed compared to their sector so far this year.
Is Alignment Healthcare (ALHC) Stock Outpacing Its Medical Peers This Year?
Neutral
Seeking Alpha
1 month ago
Alignment Healthcare, Inc. (ALHC) Q4 2024 Earnings Call Transcript
Alignment Healthcare, Inc. (NASDAQ:ALHC ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants John Kao - Founder & Chief Executive Officer Thomas Freeman - Chief Financial Officer Conference Call Participants Scott Fidel - Stephens Adam Ron - Bank of America Michael Ha - Baird Matthew Gillmor - KeyBanc Capital Markets Jessica Tassan - Piper Sandler Operator Good afternoon, and welcome to Alignment Healthcare's Fourth Quarter 2024 Earnings Conference Call and Webcast. [Operator Instructions].
Alignment Healthcare, Inc. (ALHC) Q4 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
1 month ago
Alignment Healthcare to Present at the Leerink Global Healthcare Conference and KeyBanc Capital Markets Healthcare Forum
ORANGE, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the following conferences:
Alignment Healthcare to Present at the Leerink Global Healthcare Conference and KeyBanc Capital Markets Healthcare Forum
Positive
Zacks Investment Research
1 month ago
Compared to Estimates, Alignment Healthcare (ALHC) Q4 Earnings: A Look at Key Metrics
The headline numbers for Alignment Healthcare (ALHC) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, Alignment Healthcare (ALHC) Q4 Earnings: A Look at Key Metrics
Negative
Zacks Investment Research
1 month ago
Alignment Healthcare (ALHC) Reports Q4 Loss, Tops Revenue Estimates
Alignment Healthcare (ALHC) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.25 per share a year ago.
Alignment Healthcare (ALHC) Reports Q4 Loss, Tops Revenue Estimates
Neutral
GlobeNewsWire
1 month ago
Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance
ORANGE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its fourth quarter and full year ended Dec. 31, 2024.
Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance
Neutral
Zacks Investment Research
1 month ago
Insights Into Alignment Healthcare (ALHC) Q4: Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Alignment Healthcare (ALHC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Insights Into Alignment Healthcare (ALHC) Q4: Wall Street Projections for Key Metrics
Neutral
GlobeNewsWire
1 month ago
Alignment Healthcare to Announce Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call Thursday, Feb. 27, 2025
ORANGE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its fourth quarter and full-year 2024 financial results on Thursday, Feb. 27, 2025, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EST.
Alignment Healthcare to Announce Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call Thursday, Feb. 27, 2025
Negative
Seeking Alpha
2 months ago
Focus On Costs, Regulatory Outlook For Health Insurers In Q4'24 Earnings Season
Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-side analyst forecasts. Coming off a challenging end to 2024, the upcoming earnings season is an opportunity for managed care companies to focus on 2025 expectations and Medicare Advantage growth, according to J.P. Morgan analyst Lisa Gill. UnitedHealth and Oscar Health are expected to log sequential and year-over-year revenue growth.
Focus On Costs, Regulatory Outlook For Health Insurers In Q4'24 Earnings Season
Neutral
GlobeNewsWire
2 months ago
Alignment Healthcare Announces Industry-Leading Membership Growth and Promotion of Dawn Maroney to President
ORANGE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), an award-winning Medicare Advantage (MA) company, today announced Jan. 1 health plan membership of approximately 209,900, representing a 35% year-over-year increase in health plan membership when compared to membership as of Jan. 1, 2024. Additionally, the company expects to have 225,000 to 231,000 health plan members as of Dec. 31, 2025, representing growth of approximately 22% to 25% relative to the midpoint of its year-end 2024 membership guidance provided on Oct. 29, 2024.
Alignment Healthcare Announces Industry-Leading Membership Growth and Promotion of Dawn Maroney to President
Charts implemented using Lightweight Charts™